Earnings Feed
Start Free
Blueprint Medicines Corp·4

Mar 6, 10:41 AM ET

Murray Christopher K. 4

4 · Blueprint Medicines Corp · Filed Mar 6, 2024

Insider Transaction Report

Form 4
Period: 2024-03-01
Blueprint Medicines CorpBPMC
Murray Christopher K.
SVP, Technical Operations
Transactions
  • Award

    Common Stock

    2024-03-01+12,500→ 36,995 total
  • Sale

    Common Stock

    2024-03-04$93.65/sh−621$58,157→ 36,374 total
  • Award

    Stock Option (Right to Buy)

    2024-03-01+25,000→ 25,000 total
    Exercise: $95.12Exp: 2034-03-01→ Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]The reported transaction involved the Reporting Person's receipt of grant of 12,500 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
  • [F2]Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F3]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2024 and as to an additional 1/48th of the shares underlying the option each month thereafter.

Documents

2 files